GO:0030505 inorganic diphosphate transport: Pyrophosphate Homeostasis, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0030505 (inorganic diphosphate transport) describes the directed movement of inorganic diphosphate (pyrophosphate, PPi) into, out of, or within cells via transporters or pores.
Inorganic diphosphate is a byproduct of many biosynthetic reactions and a key regulator of mineralization; its transport is essential for normal physiology.
Dysregulated PPi transport and metabolism underlie pseudoxanthoma elasticum (PXE), a heritable disorder of connective tissue.
ENPP1 is a major enzyme generating extracellular PPi, and its transport across membranes is critical for preventing ectopic calcification.
H+-translocating pyrophosphatases in protozoan parasites represent potential drug targets, highlighting the importance of PPi transport in infectious disease.
Studying inorganic diphosphate transport requires integrated approaches including CRISPR knockout, transport assays, and metabolic flux analysis.

Description

Inorganic diphosphate transport (GO:0030505) is a biological process defined as the directed movement of inorganic diphosphate (also known as pyrophosphate, PPi) into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. PPi is a small molecule generated as a byproduct of numerous biosynthetic reactions, including DNA and RNA polymerization, and it also serves as a critical regulator of biomineralization. The transport of PPi across cellular membranes is therefore essential for maintaining cellular phosphate homeostasis and for proper physiological functions, particularly in bone and connective tissues. Research into inorganic diphosphate transport has gained prominence due to its link to human diseases such as pseudoxanthoma elasticum (PXE), a genetic disorder characterized by ectopic mineralization of elastic fibers in the skin, eyes, and cardiovascular system. Mutations in the ENPP1 gene, which encodes an enzyme that produces extracellular PPi, lead to reduced PPi levels and subsequent calcification, underscoring the importance of PPi transport and metabolism. Furthermore, H+-translocating pyrophosphatases in protozoan parasites have been identified as potential targets for antiparasitic drugs, demonstrating the broad relevance of this process. Understanding the molecular players and regulatory mechanisms of inorganic diphosphate transport is crucial for developing therapeutic strategies. This article synthesizes current knowledge from authoritative sources, including QuickGO and PubMed literature, to provide a comprehensive overview of the genes, functions, and research methods associated with GO:0030505.

inorganic diphosphate transport At A Glance

GO ID GO:0030505
GO term inorganic diphosphate transport
Ontology biological_process
Synonym inorganic pyrophosphate transport
Major function Directed movement of inorganic diphosphate (PPi) across membranes
Related diseases Pseudoxanthoma elasticum (PXE), ectopic calcification disorders
Key genes ENPP1, ANKH (progressive ankylosis protein homolog), H+-translocating pyrophosphatases
Research methods CRISPR knockout, transport assays, metabolic labeling, flux analysis

What Is GO:0030505?

Inorganic diphosphate transport (GO:0030505) refers to the directed movement of inorganic diphosphate (pyrophosphate, PPi) into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is essential for maintaining cellular phosphate balance and for regulating extracellular PPi concentrations, which influence biomineralization and other physiological processes.

Why Is inorganic diphosphate transport Important in Cell Biology?

Inorganic diphosphate transport is critical for maintaining phosphate homeostasis and regulating biomineralization. Dysregulation of PPi transport leads to ectopic calcification and is implicated in pseudoxanthoma elasticum (PXE), a disorder with significant morbidity. Additionally, PPi transport is essential in protozoan parasites, where H+-translocating pyrophosphatases contribute to energy metabolism and survival, making them potential drug targets. Understanding this process provides insights into fundamental cell biology and offers therapeutic avenues for mineralization disorders and infectious diseases.
Regulates extracellular PPi levels, which inhibit ectopic calcification.
Mutations in ENPP1, which generates PPi, cause pseudoxanthoma elasticum (PXE).
PPi transport is essential for proper bone and connective tissue mineralization.
H+-translocating pyrophosphatases in protozoan parasites are potential drug targets.
Inorganic diphosphate is a byproduct of DNA/RNA synthesis, linking transport to nucleotide metabolism.
Altered PPi metabolism affects mitochondrial function and energy balance.
PPi transport influences cellular phosphate sensing and signaling.
Research on PPi transport can inform treatments for ectopic calcification disorders.
Transport assays and CRISPR models are key to dissecting PPi transport mechanisms.
Comparative studies in diatoms reveal evolutionary diversity of nucleotide transport.

What Happens During inorganic diphosphate transport?

Generation of Inorganic Diphosphate (PPi)
In simple terms: PPi is a waste product made during many building reactions in the cell.
Inorganic diphosphate (PPi) is generated as a byproduct of numerous biosynthetic reactions, including the polymerization of DNA and RNA, and the activation of fatty acids. ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) hydrolyzes ATP to produce extracellular PPi, which is crucial for inhibiting mineralization. Intracellular PPi is also produced during macromolecule synthesis and must be either transported out or hydrolyzed by pyrophosphatases to prevent accumulation.
Transport Across Membranes
In simple terms: Special proteins move PPi across cell membranes.
The directed movement of PPi across cellular membranes is mediated by specific transporters or pores. While the exact transporters for PPi in mammals are not fully characterized, the ANKH (progressive ankylosis protein homolog) is known to transport PPi and is associated with mineralization disorders. In protozoan parasites, H+-translocating pyrophosphatases pump protons while hydrolyzing PPi, indirectly influencing PPi gradients. The transport process is energy-dependent and can be coupled to proton or sodium gradients.
Regulation of Extracellular PPi Levels
In simple terms: The amount of PPi outside cells is tightly controlled to prevent calcification.
Extracellular PPi concentration is a key determinant of biomineralization. ENPP1 generates PPi outside the cell, while tissue-nonspecific alkaline phosphatase (TNAP) hydrolyzes PPi to inorganic phosphate (Pi), promoting mineralization. The balance between PPi production, transport, and degradation is critical; reduced PPi levels lead to ectopic calcification as seen in PXE. Transporters such as ANKH may facilitate PPi efflux, contributing to this balance.
Intracellular PPi Homeostasis
In simple terms: Cells must keep internal PPi levels safe by moving it or breaking it down.
Intracellular PPi must be maintained at low concentrations to avoid inhibition of essential enzymes. Inorganic pyrophosphatases (PPases) hydrolyze PPi into two phosphate ions, a reaction that is highly exergonic and drives biosynthetic reactions. In rat liver and hepatoma, PPase activity is elevated, suggesting a role in cancer metabolism. Mitochondrial PPi transport and metabolism are linked to adenine nucleotide pools and permeability transition, affecting liver regeneration.
PPi Transport in Parasites and Microorganisms
In simple terms: Some parasites use PPi transport for energy, making it a drug target.
H+-translocating pyrophosphatases (H+-PPases) are membrane-bound enzymes that couple PPi hydrolysis to proton pumping, generating a proton motive force. In protozoan parasites such as Trypanosoma and Leishmania, these enzymes are essential for survival and are absent in humans, making them attractive drug targets. Diatoms also possess unique nucleotide transport and metabolism pathways, including PPi-related processes, which are adapted to their ecological niches.

Key Genes Involved in GO:0030505 inorganic diphosphate transport

The following genes and proteins are directly involved in inorganic diphosphate transport and metabolism, based on published literature.
GeneMajor RoleResearch Relevance
ENPP1Generates extracellular PPi by hydrolyzing ATPMutations cause PXE; target for enzyme therapy
ANKHTransports PPi across membranesAssociated with craniometaphyseal dysplasia and mineralization
TNAP (ALPL)Hydrolyzes PPi to Pi, promoting mineralizationBalance with ENPP1 regulates calcification
H+-PPase (various)Couples PPi hydrolysis to proton pumpingDrug target in protozoan parasites
Inorganic pyrophosphatase (PPA1)Hydrolyzes intracellular PPiAltered in hepatoma; affects energy metabolism
Mitochondrial carriersTransport PPi and adenine nucleotidesLinked to liver regeneration and permeability transition
Nucleotide transporters (diatoms)Transport nucleotides and PPiModel for evolutionary studies
P-glycoprotein (ABCB1)Transports various substrates including nucleotidesModel for transport studies in fish hepatocytes
ATP synthaseProduces ATP, indirectly affecting PPi levelsStructural studies reveal rotary mechanism
ENPP1 variantsAltered PPi generationTherapeutic target for PXE
ANKH mutantsImpaired PPi transportCause ectopic calcification
PPA1Pyrophosphatase activityCancer metabolism
H+-PPase inhibitorsBlock PPi hydrolysisAntiparasitic drug development
Mitochondrial ATP synthaseATP productionEnergy metabolism linked to PPi
Nucleotide transport proteinsUptake of nucleotidesDiatom biology
P-gp (ABCB1)Efflux transporterXenobiotic transport

How Is inorganic diphosphate transport Regulated?

Inorganic diphosphate transport is regulated at multiple levels. The expression and activity of ENPP1 and ANKH are modulated by factors such as inorganic phosphate (Pi) and pyrophosphate levels themselves, as well as hormones like vitamin D and PTH. In parasites, H+-PPase activity is regulated by proton gradients and cellular energy status. Additionally, mitochondrial PPi transport is influenced by adenine nucleotide pools and the permeability transition pore, which affects liver regeneration. However, specific transcriptional regulators of PPi transporters remain poorly defined.

inorganic diphosphate transport and Human Disease

GeneDisease / BiologyPotential Experimental Model
ENPP1Pseudoxanthoma elasticum, GACIEnpp1 knockout mouse, patient iPSCs
ANKHCraniometaphyseal dysplasiaAnkh mutant mouse, osteoblast cultures
ABCC6PXEAbcc6 knockout mouse, hepatocyte models
H+-PPaseParasitic infectionsParasite cultures, enzyme assays
PPA1Cancer metabolismHepatoma cell lines, xenografts
Pseudoxanthoma Elasticum (PXE)
PXE is a genetic disorder caused by mutations in ABCC6, leading to reduced plasma PPi levels and ectopic mineralization of elastic fibers. ENPP1, which generates PPi, is also implicated; recombinant ENPP1 enzyme therapy is being explored as a treatment. The disease affects skin, eyes, and cardiovascular system, highlighting the importance of PPi transport and metabolism in connective tissue homeostasis.
Ectopic Calcification Disorders
Generalized arterial calcification of infancy (GACI) is caused by mutations in ENPP1, resulting in low PPi and severe arterial calcification. ANKH mutations cause craniometaphyseal dysplasia, a bone disorder characterized by hyperostosis. These conditions underscore the critical role of PPi transport in preventing pathological mineralization.
Parasitic Infections
H+-translocating pyrophosphatases are essential for the survival of protozoan parasites such as Trypanosoma cruzi and Leishmania species. These enzymes are absent in humans, making them selective drug targets. Inhibitors of H+-PPases could potentially treat Chagas disease and leishmaniasis.
Cancer Metabolism
Inorganic pyrophosphatase activity is elevated in hepatoma compared to normal liver, suggesting altered PPi metabolism in cancer. Mitochondrial PPi transport and adenine nucleotide pools are linked to liver regeneration and may influence tumor growth. Targeting PPi transport pathways could offer novel therapeutic strategies.

From inorganic diphosphate transport-Related Genes to Experimental Models

Research QuestionSuitable Model
Does ENPP1 loss alter PPi transport and calcification?ENPP1 knockout mouse or CRISPR KO in osteoblasts
What is the effect of ANKH point mutations on PPi transport?Knock-in of patient mutations in cell lines
Can tagged ANKH be used to track PPi transport?Tagged knock-in (e.g., GFP) in mammalian cells
Does overexpression of H+-PPase increase proton pumping?Overexpression in parasite or yeast models
How does PPi transport affect mitochondrial function?Mitochondrial isolation from KO models
Can CRISPR library screening identify novel PPi transporters?Genome-wide CRISPR knockout screen in calcifying cells

How to Study the inorganic diphosphate transport Process

MethodWhat It MeasuresTypical Application
Radiolabeled PPi transport assayRate of PPi uptake/effluxCharacterizing transporter kinetics
CRISPR knockoutGene functionIdentifying essential PPi transporters
Fluorescent PPi probesIntracellular PPi levelsLive-cell imaging
Metabolic flux analysisPPi production and consumptionQuantifying pathway activity
Cryo-EMProtein structureUnderstanding transport mechanism
qPCR/Western blotExpression levelsValidating knockout/overexpression
Mineralization assaysCalcium depositionAssessing functional impact of PPi transport
Transport Assays
Radiolabeled PPi or fluorescent analogs can be used to measure transport across membrane vesicles or intact cells. For example, P-gp-mediated transport of doxorubicin in rainbow trout hepatocytes was characterized using functional and energetic assays. Similar approaches can be adapted for PPi transporters.
CRISPR-Cas9 Knockout Studies
Knockout of candidate genes such as ENPP1 or ANKH in cell lines (e.g., HEK293, osteoblasts) allows assessment of their role in PPi transport and mineralization. CRISPR libraries can screen for novel transporters.
Metabolic Flux Analysis
Isotope tracing with 32P or 13C can quantify PPi production and transport rates. In diatoms, nucleotide transport and metabolism have been studied using such methods.
Structural Biology
Cryo-EM and X-ray crystallography can reveal the structure of PPi transporters. For example, the structure of mitochondrial ATP synthase was determined in situ using cryo-electron tomography, providing a template for studying membrane transporters.

How CRISPR Can Be Used to Study GO:0030505 inorganic diphosphate transport

Knockout

CRISPR knockout of ENPP1 or ANKH in cell models can abolish PPi transport, leading to reduced extracellular PPi and increased mineralization. These models are valuable for studying PXE and related disorders.

Point Mutation

Introducing patient-specific point mutations (e.g., in ANKH) via CRISPR knock-in allows precise modeling of transport defects and testing of corrective therapies.

Knock-in

Tagged knock-in of transporters (e.g., GFP-ANKH) enables live-cell imaging and proteomic analysis of PPi transport dynamics.

Overexpression

Overexpression of H+-PPases in parasite or mammalian cells can enhance PPi hydrolysis and proton pumping, useful for drug screening and mechanistic studies.

How EDITGENE Supports inorganic diphosphate transport Research

Researchers studying inorganic diphosphate transport-related genes often need to determine whether a candidate gene is causally involved in PPi movement, mineralization, or disease. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for inorganic diphosphate transport research.

Frequently Asked Questions About inorganic diphosphate transport

Inorganic diphosphate transport (GO:0030505) is the directed movement of inorganic diphosphate (pyrophosphate, PPi) into, out of, or within a cell, or between cells, by means of a transporter or pore.
Key genes include ENPP1, which generates extracellular PPi, and ANKH, which transports PPi across membranes. H+-translocating pyrophosphatases in parasites also mediate PPi transport.
PXE is caused by mutations in ABCC6 and is associated with reduced plasma PPi. ENPP1, which produces PPi, is also implicated, and enzyme therapy is being developed.
ENPP1 hydrolyzes ATP to generate extracellular PPi, which inhibits calcification. Its transport and metabolism are critical for preventing ectopic mineralization.
Yes, CRISPR knockout of ENPP1 or ANKH can model PPi transport defects, and knock-in of tagged transporters enables imaging.
Diseases include pseudoxanthoma elasticum, generalized arterial calcification of infancy, and craniometaphyseal dysplasia.
These enzymes couple PPi hydrolysis to proton pumping, generating a proton motive force. They are essential in protozoan parasites and are drug targets.
Methods include radiolabeled PPi transport assays, fluorescent probes, CRISPR screens, and metabolic flux analysis.
Altered pyrophosphatase activity has been observed in hepatoma, suggesting a role in cancer metabolism.
Models include knockout mice, patient-derived iPSCs, and CRISPR-engineered cell lines.

Conclusion

Inorganic diphosphate transport (GO:0030505) is a fundamental biological process that regulates phosphate homeostasis and biomineralization. Its dysfunction is linked to severe disorders such as pseudoxanthoma elasticum and ectopic calcification, as well as parasitic infections. Continued research using CRISPR and advanced imaging will unravel the molecular mechanisms and identify therapeutic targets. EDITGENE offers a suite of CRISPR services to support these investigations.

References

  1. 1. Germain DP. 2017. Pseudoxanthoma elasticum.. Orphanet J Rare Dis 12(1):85 PMID: 28486967
  2. 2. Hildebrand JL et al.. 2009. Functional and energetic characterization of P-gp-mediated doxorubicin transport in rainbow trout (Oncorhynchus mykiss) hepatocytes.. Comp Biochem Physiol C Toxicol Pharmacol 149(1):65-72 PMID: 18664392
  3. 3. Jacobs IJ et al.. 2024. Novel treatment for PXE: Recombinant ENPP1 enzyme therapy.. Mol Ther 32(11):3815-3820 PMID: 39342427
  4. 4. Dietrich L et al.. 2024. In situ structure and rotary states of mitochondrial ATP synthase in whole Polytomella cells.. Science 385(6713):1086-1090 PMID: 39236170
  5. 5. Yoshida C et al.. 1982. Purification and properties of inorganic pyrophosphatase of rat liver and hepatoma 3924A.. Cancer Res 42(9):3526-31 PMID: 6125258
  6. 6. Araujo-Ruiz K et al.. 2024. H(+)-translocating pyrophosphatases in protozoan parasites.. Parasitol Res 123(10):353 PMID: 39419910
  7. 7. Hernández-Muñoz R et al.. 2003. Changes in mitochondrial adenine nucleotides and in permeability transition in two models of rat liver regeneration.. Hepatology 37(4):842-51 PMID: 12668977
  8. 8. Gruber A et al.. 2019. Nucleotide Transport and Metabolism in Diatoms.. Biomolecules 9(12) PMID: 31766535
Contact Us
*
*
*
*
How did you hear about us: